March 20, 2013
AstraZeneca AB launched a suit Tuesday in New Jersey federal court accusing drugmaker Actavis Inc. of infringing five of its patents for the heartburn drug Nexium by seeking federal approval to make and sell a generic version of Nexium's active ingredient.